Mu-opioid antagonism in the treatment of cannabis use disorder

Mu-opioid antagonism in the treatment of cannabis use disorder

J Psychiatry Neurosci 2020;45(2):143-144 | PDF

Oussama Kebir, MD, PhD; Xavier Laqueille, MD; Fayçal Mouaffak, MD, PhD


Affiliations: From the Service d’Addictologie Moreau de Tours, Centre hospitalier Sainte Anne, GHU Paris Psychiatrie & Neurosciences, Paris, France (Kebir, Laqueille); the Laboratoire physiopathologie des maladies psychiatriques, Institut de Psychiatrie et Neurosciences de Paris, INSERM U1266, Paris, France (Kebir); and the Unité de Psychiatrie de Liaison, d’Urgence et de Recherche, Pôle 93G04, EPS Ville Evrard, Saint Denis, France (Mouaffak).

Competing interests: None declared.

DOI: 10.1503/jpn.190182